We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$434M
AUM Growth
-$19.7M
Cap. Flow
-$23.7M
Cap. Flow %
-5.45%
Top 10 Hldgs %
30.83%
Holding
124
New
5
Increased
9
Reduced
61
Closed
4

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.63M
2
IYK icon
iShares US Consumer Staples ETF
IYK
+$713K
3
RSP icon
Invesco S&P 500 Equal Weight ETF
RSP
+$594K
4
PFF icon
iShares Preferred and Income Securities ETF
PFF
+$536K
5
EQIX icon
Equinix
EQIX
+$401K

Top Sells

Rank Stock Value
1
BNY
Bank of New York Mellon
BNY
+$2.15M
2
WMT icon
Walmart Inc
WMT
+$1.76M
3
BBH icon
VanEck Biotech ETF
BBH
+$1.73M
4
IBB icon
iShares Biotechnology ETF
IBB
+$1.58M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.48M

Sector Composition

Rank Sector Weight
1 Technology 14.75%
2 Healthcare 12.01%
3 Financials 10.55%
4 Consumer Staples 10.22%
5 Industrials 9.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RTX icon
101
RTX Corp
RTX
$299B
$299K 0.07%
1,635
– –
KMB icon
102
Kimberly-Clark
KMB
$37.1B
$298K 0.07%
2,955
-75
-2% -$8.2K
AXP icon
103
American Express
AXP
$236B
$295K 0.07%
800
– –
GPC icon
104
Genuine Parts
GPC
$18.1B
$293K 0.07%
2,390
– –
IWB icon
105
iShares Russell 1000 ETF
IWB
$49.9B
$286K 0.07%
768
– –
BA icon
106
Boeing
BA
$190B
$282K 0.07%
1,300
– –
GS icon
107
Goldman Sachs
GS
$315B
$263K 0.06%
300
– –
GD icon
108
General Dynamics
GD
$104B
$259K 0.06%
770
– –
MAS icon
109
Masco
MAS
$15.3B
$253K 0.06%
4,000
– –
AMAT icon
110
Applied Materials
AMAT
$431B
$250K 0.06%
+975
New +$234K
COST icon
111
Costco
COST
$417B
$250K 0.06%
290
-100
-26% -$90.6K
UNH icon
112
UnitedHealth
UNH
$377B
$244K 0.06%
740
– –
A icon
113
Agilent Technologies
A
$39.6B
$236K 0.05%
1,737
– –
LOW icon
114
Lowe's Companies
LOW
$122B
$236K 0.05%
980
– –
CHRW icon
115
C.H. Robinson
CHRW
$18B
$223K 0.05%
+1,390
New +$205K
YUMC icon
116
Yum China
YUMC
$16.3B
$209K 0.05%
+4,389
New +$201K
AFL icon
117
Aflac
AFL
$63.6B
$207K 0.05%
1,880
– –
CVS icon
118
CVS Health
CVS
$127B
$201K 0.05%
+2,539
New +$200K
WEC icon
119
WEC Energy
WEC
$35.2B
$200K 0.05%
1,902
– –
ESBA icon
120
Empire State Realty Series ES
ESBA
$1.35B
$67K 0.02%
10,754
– –
ANET icon
121
Arista Networks
ANET
$254B
– –
-1,600
Closed -$233K
BBH icon
122
VanEck Biotech ETF
BBH
$410M
– –
-10,446
Closed -$1.73M
HPQ icon
123
HP
HPQ
$26.4B
– –
-8,680
Closed -$236K
IBB icon
124
iShares Biotechnology ETF
IBB
$9.44B
– –
-10,978
Closed -$1.58M
1 2 3 4
5

Similar funds

SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
TFP
Triune Financial Partners Overland Park, Kansas $421M AUM 22.09% 1-Year Est. Return
AI
ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return
CMHI
CVC Management Holdings II St. Helier, Jersey $420M AUM 0.05% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
CWAF
Core Wealth Advisors (Florida) Lakeland, Florida $419M AUM 16.86% 1-Year Est. Return
MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Boston Research & Management's Q4 2025 Portfolio in Review

As of Q4 2025, Boston Research & Management held 124 positions worth $434M, down 4.3% from $453M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Boston Research & Management withdrew a net $23.7M in Q4 2025, closing 4 positions and reducing 61 holdings. Its most notable exit was VanEck Biotech ETF, an estimated $1.73M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Boston Research & Management opened a new position in iShares US Consumer Staples ETF worth $702K.

  • Boston Research & Management's largest Q4 2025 buy was iShares US Consumer Staples ETF: 10,500 shares worth $702K.
  • Boston Research & Management added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $1.63M increase.
  • Boston Research & Management's biggest Q4 2025 reduction was Bank of New York Mellon, cutting an estimated $2.15M.
  • Boston Research & Management fully exited VanEck Biotech ETF in Q4 2025, selling an estimated $1.73M.
  • Boston Research & Management's ten largest holdings make up 31% of its $434M portfolio in Q4 2025.
  • Boston Research & Management opened 5 new positions and closed 4 in Q4 2025.
  • Boston Research & Management's portfolio value fell 4.3% quarter-over-quarter to $434M.

Based on Boston Research & Management's 13F filing for Q4 2025, filed 11 Feb 2026.